These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8530543

  • 21. Bis(7)-tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemia.
    Zhao Y, Li W, Chow PC, Lau DT, Lee NT, Pang Y, Zhang X, Wang X, Han Y.
    Neurosci Lett; 2008 Jul 11; 439(2):160-4. PubMed ID: 18515007
    [Abstract] [Full Text] [Related]

  • 22. Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia.
    Berger C, Stauder A, Xia F, Sommer C, Schwab S.
    Exp Neurol; 2008 Apr 11; 210(2):543-8. PubMed ID: 18187132
    [Abstract] [Full Text] [Related]

  • 23. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
    Candelario-Jalil E, González-Falcón A, García-Cabrera M, León OS, Fiebich BL.
    Brain Res; 2004 May 08; 1007(1-2):98-108. PubMed ID: 15064140
    [Abstract] [Full Text] [Related]

  • 24. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies.
    Williams AJ, Dave JR, Phillips JB, Lin Y, McCabe RT, Tortella FC.
    J Pharmacol Exp Ther; 2000 Jul 08; 294(1):378-86. PubMed ID: 10871336
    [Abstract] [Full Text] [Related]

  • 25. [NMDA receptor antagonists in focal cerebral ischemia. An experimental model].
    Nathal E, Miquelajauregui JM, Herreman F, Alvarado R, Romero V, Mateos Gomez JH.
    Gac Med Mex; 1993 Jul 08; 129(2):125-30. PubMed ID: 7926393
    [Abstract] [Full Text] [Related]

  • 26. On-line monitoring of striatum glucose and lactate in the endothelin-1 rat model of transient focal cerebral ischemia using microdialysis and flow-injection analysis with biosensors.
    Gramsbergen JB, Skjøth-Rasmussen J, Rasmussen C, Lambertsen KL.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):93-101. PubMed ID: 15589339
    [Abstract] [Full Text] [Related]

  • 27. Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion.
    Zhang F, Li C, Wang R, Han D, Zhang QG, Zhou C, Yu HM, Zhang GY.
    Neuroscience; 2007 Dec 19; 150(4):938-49. PubMed ID: 18022328
    [Abstract] [Full Text] [Related]

  • 28. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction.
    Ren M, Leng Y, Jeong M, Leeds PR, Chuang DM.
    J Neurochem; 2004 Jun 19; 89(6):1358-67. PubMed ID: 15189338
    [Abstract] [Full Text] [Related]

  • 29. Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats.
    Horiguchi T, Snipes JA, Kis B, Shimizu K, Busija DW.
    Neuroscience; 2006 Jun 30; 140(2):723-30. PubMed ID: 16567054
    [Abstract] [Full Text] [Related]

  • 30. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
    Katsuta K, Nakanishi H, Shirakawa K, Yoshida K, Takagi K, Tamura A.
    J Cereb Blood Flow Metab; 1995 Mar 30; 15(2):345-8. PubMed ID: 7860668
    [Abstract] [Full Text] [Related]

  • 31. Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia.
    Moyanova SG, Kortenska LV, Mitreva RG, Pashova VD, Ngomba RT, Nicoletti F.
    Brain Res; 2007 Jun 11; 1153():58-67. PubMed ID: 17466282
    [Abstract] [Full Text] [Related]

  • 32. Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia.
    Yang G, Chan PH, Chen SF, Babuna OA, Simon RP, Weinstein PR.
    Neurosurgery; 1994 Feb 11; 34(2):339-45; discussion 345. PubMed ID: 8177396
    [Abstract] [Full Text] [Related]

  • 33. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.
    Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gómez-Isla T, Hyman BT, Moskowitz MA.
    J Cereb Blood Flow Metab; 1998 Mar 11; 18(3):238-47. PubMed ID: 9498840
    [Abstract] [Full Text] [Related]

  • 34. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
    Lumenta DB, Plesnila N, Kläsner B, Baethmann A, Pruneau D, Schmid-Elsaesser R, Zausinger S.
    Brain Res; 2006 Jan 19; 1069(1):227-34. PubMed ID: 16378603
    [Abstract] [Full Text] [Related]

  • 35. Pre-ischemic treadmill training affects glutamate and gamma aminobutyric acid levels in the striatal dialysate of a rat model of cerebral ischemia.
    Jia J, Hu YS, Wu Y, Liu G, Yu HX, Zheng QP, Zhu DN, Xia CM, Cao ZJ.
    Life Sci; 2009 Apr 10; 84(15-16):505-11. PubMed ID: 19302809
    [Abstract] [Full Text] [Related]

  • 36. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    Graham SH, Chen J, Lan JQ, Simon RP.
    J Pharmacol Exp Ther; 1996 Jan 10; 276(1):1-4. PubMed ID: 8558416
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.
    Chen M, Bullock R, Graham DI, Frey P, Lowe D, McCulloch J.
    Ann Neurol; 1991 Jul 10; 30(1):62-70. PubMed ID: 1834008
    [Abstract] [Full Text] [Related]

  • 38. Post-ischemic RSR13 amplifies the effect of dizocilpine on outcome from transient focal cerebral ischemia in the rat.
    Mackensen GB, Nellgård B, Sarraf-Yazdi S, Dexter F, Steffen RP, Grocott HP, Warner DS.
    Brain Res; 2000 Jan 17; 853(1):15-21. PubMed ID: 10627303
    [Abstract] [Full Text] [Related]

  • 39. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA, Graham DI, McCulloch J, Macrae IM.
    Br J Pharmacol; 1994 Sep 17; 113(1):247-53. PubMed ID: 7529111
    [Abstract] [Full Text] [Related]

  • 40. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
    Buchan AM, Slivka A, Xue D.
    Brain Res; 1992 Mar 06; 574(1-2):171-7. PubMed ID: 1386274
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.